The EU and US recently rolled out two historic capital markets regulations, both of which are intended to increase transparency in the global OTC derivatives market following the financial crisis.
But a lack of clarity around the technical implementation of these reforms in OTC derivatives trading brought to the fore the possibility that many market participants might not be able to comply with the regulations prior to their implementation deadlines, raising questions about whether cross-border reforms will truly result in a more transparent global market.
GreySpark Partners consultant Malavika Shekar explores the practical difficulties faced by regulators in implementing OTC derivative reforms on a global scale.
